Malnar, Martina <br/><br/>
Use of cerebrospinal fluid biomarker analysis for improving Alzheimer's disease diagnosis in a non-specialized setting.  [electronic resource] 

 -  Acta neurobiologiae experimentalis  2012 
 - 264-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1689-0035 
<br/><br/><label>Standard No.: </label>10.55782/ane-2012-1899  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alzheimer Disease--cerebrospinal fluid<br/>Amyloid beta-Peptides--cerebrospinal fluid<br/>Apolipoproteins E--genetics<br/>Biomarkers--cerebrospinal fluid<br/>Cognitive Dysfunction--cerebrospinal fluid<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Psychiatric Status Rating Scales<br/>Statistics, Nonparametric<br/>tau Proteins--cerebrospinal fluid